Dolasteron 多拉司琼

CAS 115956-12-2 MFCD15956122

化学结构图

115956-12-2
SMILES: O=C1C[N@@]2[C@@H]3CC1C[C@H]2C[C@H](C3)OC(=O)c1c[nH]c2ccccc12

化学属性

Mol. FormulaC19H20N2O3
Mol. Weight324

别名和识别编码

Chemical NameDolasteron
Synonym 多拉司琼中间体
InChIKeyUKTAZPQNNNJVKR-MMUVGSQPSA-N
Chemical Name Translation多拉司琼
MDL Number
CAS Number115956-12-2
信息真实价格透明    资金保障    专业采购外包团队在线服务   
信息真实价格透明    资金保障    专业采购外包团队在线服务   
品牌质保精细包装    现货库存    一流品牌服务   

相关文献及参考

  • [2]. Schwartzberg L, et al. Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer. 2014 Feb;22(2):469-77.
  • [1]. Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8.
  • [1]. Faria C, et al. Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis. Am Health Drug Benefits. 2014 Jan;7(1):50-8.
  • [2]. Schwartzberg L, et al. Pooled analysis of phase III clinical studies of palonosetron versus ondansetron, dolasetron, and granisetron in the prevention of chemotherapy-induced nausea and vomiting (CINV). Support Care Cancer. 2014 Feb;22(2):469-77.

系列性分类

  1. Medical Research Areas
  2. GPCR & G Protein
  3. 5-HT Receptor  (5-羟色胺受体)

相关产品推荐